Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $9.7 million.

  • National Healthcare's Capital Expenditures rose 7164.07% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.2 million, marking a year-over-year increase of 2196.47%. This contributed to the annual value of $27.6 million for FY2024, which is 107.88% down from last year.
  • Per National Healthcare's latest filing, its Capital Expenditures stood at $9.7 million for Q3 2025, which was up 7164.07% from $10.2 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Capital Expenditures ranged from a high of $13.6 million in Q4 2021 and a low of $4.3 million during Q1 2021
  • For the 5-year period, National Healthcare's Capital Expenditures averaged around $8.0 million, with its median value being $7.8 million (2024).
  • Per our database at Business Quant, National Healthcare's Capital Expenditures soared by 22783.93% in 2021 and then tumbled by 5862.75% in 2022.
  • Over the past 5 years, National Healthcare's Capital Expenditures (Quarter) stood at $13.6 million in 2021, then tumbled by 58.63% to $5.6 million in 2022, then surged by 52.58% to $8.6 million in 2023, then fell by 5.17% to $8.2 million in 2024, then grew by 19.03% to $9.7 million in 2025.
  • Its Capital Expenditures stands at $9.7 million for Q3 2025, versus $10.2 million for Q2 2025 and $6.1 million for Q1 2025.